MGC Pharmaceuticals (ASX: MXC)
MGC Pharmaceuticals (ASX: MXC) is a EU based specialist medical cannabis company with many years of technical, clinical and commercial experience in the medical cannabis industry. www.mgcpharma.com.au
MGC Pharmaceuticals receives cannabis research and import permit grants in Australia
MGC Pharmaceuticals (ASX: MXC) has reached yet another regulatory milestone after the biopharmaceutical company confirmed it has been granted a ...
MGC Pharma expands ArtemiC Phase II trial to include COVID-19 patients in India
MGC Pharmaceuticals (ASX: MXC) has confirmed the footprint of a Phase II trial into the efficacy of its ArtemiC anti-inflammatory medicated spra...
MGC Pharma and Micelle Technology to begin clinical trial using anti-infective drug on COVID-19 patients
MGC Pharmaceuticals (ASX: MXC) is about to kick-off a phase II clinical trial evaluating a natural anti-infective drug on COVID-19 patients.
...
MGC Pharmaceuticals presents ‘ground-breaking’ research into effect of cannabis on brain cancer
Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) has completed what it calls “ground-breaking research” that highlights the effectivenes...
MGC Pharma officially enters UK with CannEpil distribution to begin immediately
Medicinal cannabis producer MGC Pharmaceuticals’ (ASX: MXC) first CannEpil shipment to the UK has landed on British soil and will be immediately...
MGC Pharmaceuticals enters Chinese market with CBD products
Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) is entering the Chinese health market, inking a deal with e-commerce import platform Yu...
MGC Pharmaceuticals receives TGA approval to market its CannEpil medicinal cannabis product in Australia
Aspiring bio-pharmaceutical company MGC Pharmaceuticals (ASX: MXC) has received formal authorisation to supply its CannEpil product through spec...
MGC Pharmaceuticals positions cannabis as a potential treatment in the fight against dementia
Biopharma developer MGC Pharmaceuticals (ASX: MXC) plans to apply the potential benefits of cannabis to mitigate the impact of dementia.
Earl...
UK’s Harvey Nichols to expand MGC Pharmaceuticals CBD Derma range
MGC Pharmaceuticals (ASX: MXC) has received strong commercial news this morning with the news that UK-based retailer Harvey Nichols has decided ...
MGC Pharmaceuticals receives key medical cannabis certification and manufacturing licence
Biopharma company MGC Pharmaceuticals (ASX: MXC) has received its GMP certification and formal manufacturing licence to produce Good Manufacturi...
MGC Pharmaceuticals celebrates medical cannabis legislative change in Malta
The final piece of its cannabis production line has now slotted into place for MGC Pharmaceuticals (ASX: MXC) after final legislation was passed...
MGC Pharmaceuticals launches latest cannabidiol skincare product
Medicinal cannabis and its expansive set of applications continue to encroach upon commercial markets with MGC Pharmaceuticals (ASX: MXC) launch...
MGC Pharma gets go-ahead to build medical cannabis facility in Malta, tops up cash
MGC Pharma (ASX: MXC) has grown its medical cannabis production capabilities after the Maltese Government gave the company the go-ahead to const...
MGC Pharmaceuticals commences production of CannEpil product for epilepsy
Medicinal cannabis is emerging into mainstream consumption, one approval at a time for MGC Pharmaceuticals (ASX: MXC).
As one of the world’s ...
MGC Pharma’s cannabidiol cosmetics launch on Cult Beauty online store
Australian medicinal cannabis company MGC Pharmaceuticals (ASX: MXC) has officially launched its range of MGC Derma and Derma Plus cannabidiol (...
MGC Pharma granted green light to start manufacturing CannEpil for distribution
MGC Pharmaceuticals (ASX: MXC) has been given the greenlight to begin manufacturing its medicinal cannabis-based products at its European produc...
MGC Pharma gains cosmetics distribution boost via Cult Beauty
MGC Pharmaceuticals (ASX: MXC), an Australian medicinal cannabis company, has announced that its European subsidiary MGC Derma has signed a sale...
MGC Pharma’s cannabis-based herbal cream now available for psoriasis sufferers
MGC Pharmaceuticals (ASX: MXC) has officially launched its cannabidiol-based Derma Plus herbal cream for psoriasis sufferers throughout Australa...
MGC Pharma to launch CBD-based psoriasis cream next month
Psoriasis suffers will have a new treatment available from January 1st next year after MGC Pharmaceuticals (ASX: MXC) scheduled the launch for i...
MGC Pharmaceuticals secures CBD extract supply agreement worth $1m
MGC Pharmaceuticals (ASX: MXC) has secured yet another supply agreement, this time with European distributor Mabsut Life, with this contract, al...
MGC Pharma breaks into Australian pharmaceutical market with epilepsy drug
MGC Pharmaceuticals (ASX: MXC) has inked a heads of agreement with Australian distributor HL Pharma Pty Ltd to distribute its CannEpil product t...
